Elias Oussedik

684 total citations
19 papers, 445 citations indexed

About

Elias Oussedik is a scholar working on Dermatology, Immunology and Economics and Econometrics. According to data from OpenAlex, Elias Oussedik has authored 19 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 7 papers in Immunology and 4 papers in Economics and Econometrics. Recurrent topics in Elias Oussedik's work include Dermatology and Skin Diseases (6 papers), Psoriasis: Treatment and Pathogenesis (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Elias Oussedik is often cited by papers focused on Dermatology and Skin Diseases (6 papers), Psoriasis: Treatment and Pathogenesis (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Elias Oussedik collaborates with scholars based in United States, Canada and Italy. Elias Oussedik's co-authors include Steven R. Feldman, Leah A. Cardwell, Jerry Tan, Marc Bourcier, Nupur Patel, Olabola Awosika, Jennifer J. Schoch, Mauro Picardo, Lara K. Kammrath and E. J. Masicampo and has published in prestigious journals such as Journal of the American Academy of Dermatology, Clinical Pharmacology & Therapeutics and JAMA Dermatology.

In The Last Decade

Elias Oussedik

19 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elias Oussedik United States 11 221 159 62 55 48 19 445
Leah A. Cardwell United States 13 308 1.4× 220 1.4× 68 1.1× 52 0.9× 57 1.2× 46 557
Melissa Danesh United States 11 203 0.9× 121 0.8× 56 0.9× 29 0.5× 34 0.7× 34 397
Kourosh Beroukhim United States 12 247 1.1× 300 1.9× 57 0.9× 17 0.3× 46 1.0× 33 545
Muhterem Polat Türkiye 12 235 1.1× 75 0.5× 102 1.6× 28 0.5× 49 1.0× 40 420
Surabhi Dayal India 15 357 1.6× 80 0.5× 68 1.1× 29 0.5× 39 0.8× 86 641
Crystal Aguh United States 14 304 1.4× 43 0.3× 76 1.2× 36 0.7× 56 1.2× 46 517
Kıymet Baz Türkiye 12 357 1.6× 138 0.9× 89 1.4× 38 0.7× 68 1.4× 27 688
Simona Giancristoforo Italy 12 246 1.1× 186 1.2× 56 0.9× 36 0.7× 56 1.2× 40 558
Yashpal Manchanda India 12 142 0.6× 68 0.4× 79 1.3× 23 0.4× 35 0.7× 32 345
Luna Azulay‐Abulafia Brazil 14 338 1.5× 118 0.7× 105 1.7× 54 1.0× 38 0.8× 59 661

Countries citing papers authored by Elias Oussedik

Since Specialization
Citations

This map shows the geographic impact of Elias Oussedik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Oussedik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Oussedik more than expected).

Fields of papers citing papers by Elias Oussedik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias Oussedik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Oussedik. The network helps show where Elias Oussedik may publish in the future.

Co-authorship network of co-authors of Elias Oussedik

This figure shows the co-authorship network connecting the top 25 collaborators of Elias Oussedik. A scholar is included among the top collaborators of Elias Oussedik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elias Oussedik. Elias Oussedik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Oussedik, Elias, Abigail Cline, Jennifer Su, et al.. (2019). <p>Accountability in patient adherence</p>. Patient Preference and Adherence. Volume 13. 1511–1517. 6 indexed citations
2.
Oussedik, Elias, et al.. (2018). Acquired disorders with hypopigmentation: A clinical approach to diagnosis and treatment. Journal of the American Academy of Dermatology. 80(5). 1233–1250.e10. 23 indexed citations
3.
Cardwell, Leah A., et al.. (2018). Psoriasis and Atopic Dermatitis “Resistant” to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray. Journal of Cutaneous Medicine and Surgery. 23(2). 157–163. 6 indexed citations
4.
Oussedik, Elias, et al.. (2018). Acquired disorders with depigmentation: A systematic approach to vitiliginoid conditions. Journal of the American Academy of Dermatology. 80(5). 1215–1231.e6. 14 indexed citations
5.
Patel, Nupur, et al.. (2018). A Case Report Highlighting the Effective Treatment of Alopecia Universalis With Tofacitinib in an Adolescent and Adult Patient. Journal of Cutaneous Medicine and Surgery. 22(4). 439–442. 20 indexed citations
6.
Cardwell, Leah A., et al.. (2018). Patients preferences for different corticosteroid vehicles are highly variable. Journal of Dermatological Treatment. 31(2). 147–151. 16 indexed citations
7.
Jackson, David G., Leah A. Cardwell, Elias Oussedik, & Steven R. Feldman. (2017). Utility of boron in dermatology. Journal of Dermatological Treatment. 31(1). 2–12. 7 indexed citations
8.
Oussedik, Elias, Marc Bourcier, & Jerry Tan. (2017). Psychosocial Burden and Other Impacts of Rosacea on Patients’ Quality of Life. Dermatologic Clinics. 36(2). 103–113. 48 indexed citations
9.
Awosika, Olabola & Elias Oussedik. (2017). Genetic Predisposition to Rosacea. Dermatologic Clinics. 36(2). 87–92. 21 indexed citations
10.
Oussedik, Elias, et al.. (2017). Accountability: a missing construct in models of adherence behavior and in clinical practice. Patient Preference and Adherence. Volume 11. 1285–1294. 41 indexed citations
11.
Cardwell, Leah A., et al.. (2017). TNF Inhibitors for Psoriasis and Psoriatic Arthritis. Current Dermatology Reports. 6(2). 113–120. 1 indexed citations
12.
Oussedik, Elias, et al.. (2017). Interleukin-31 pathway and its role in atopic dermatitis: a systematic review. Journal of Dermatological Treatment. 28(7). 591–599. 51 indexed citations
13.
Oussedik, Elias, et al.. (2017). An Anchoring-Based Intervention to Increase Patient Willingness to Use Injectable Medication in Psoriasis. JAMA Dermatology. 153(9). 932–932. 13 indexed citations
14.
Oussedik, Elias, Michael S. Anderson, & Steven R. Feldman. (2017). Risk versus benefit or risk versus risk: Risk aversion in the medical decision making process. Journal of Dermatological Treatment. 28(1). 1–2. 16 indexed citations
15.
Oussedik, Elias, et al.. (2017). Recent Advances in Small Molecule and Biological Therapeutic Approaches in the Treatment of Psoriasis. Clinical Pharmacology & Therapeutics. 102(1). 70–85. 9 indexed citations
16.
Patel, Nupur, et al.. (2017). Early Congenital Syphilis: Recognising Symptoms of an Increasingly Prevalent Disease. Journal of Cutaneous Medicine and Surgery. 22(1). 97–99. 7 indexed citations
17.
Oussedik, Elias, et al.. (2017). A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation.. PubMed. 16(10). 972–975. 4 indexed citations
18.
Oussedik, Elias, et al.. (2017). Severe and acute complications of biologics in psoriasis. Italian Journal of Dermatology and Venereology. 152(6). 9 indexed citations
19.
Cardwell, Leah A., et al.. (2017). Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease. Journal of Dermatological Treatment. 29(1). 13–18. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026